Literature DB >> 31464387

Mitochondrial Hyperacetylation in the Failing Hearts of Obese Patients Mediated Partly by a Reduction in SIRT3: The Involvement of the Mitochondrial Permeability Transition Pore.

Elena C Castillo1, José A Morales1, Héctor Chapoy-Villanueva1, Christian Silva-Platas1, Niria Treviño-Saldaña1, C Enrique Guerrero-Beltrán1,2, Judith Bernal-Ramírez1, Alejandro Torres-Quintanilla1, Noemí García1,2, Keith Youker3, Guillermo Torre-Amione1,2,3, Gerardo García-Rivas1,4.   

Abstract

BACKGROUND/AIMS: Cyclophilin D (CypD) mediates the mitochondrial permeability transition pore (mPTP) opening that contributes to mitochondrial dysfunction. CypD is regulated by its acetylation/deacetylation state that depends on Sirtuin-3 (SIRT3) mitochondrial deacetylase. Since obesity and metabolic syndrome decrease SIRT3 activity and expression, we tested the hypothesis that CypD hyperacetylation promotes mitochondrial dysfunction under this pathophysiological state, which is associated with ventricular dysfunction and heart failure.
METHODS: Myocardial tissue samples from patients with left ventricular heart failure, with either obesity or normal weight, were processed for the expression of SIRT3 and acetylation profile by Western Blot (WB). In addition, a rat model of obesity and metabolic syndrome induced by 30% (w/v) of sucrose was conducted. The WB analysis was used to determine the levels of mitochondrial expression of SIRT3, Adenine Nucleotide Translocator (ANT), CypD and the acetylation profile, as well as immunoprecipitation to establish the acetylation levels of CypD. Mitochondrial function was assessed by oxygen consumption analysis and maximum Ca2+ retention capacity. Oxidative stress was assessed by aconitase activity, protein carbonyl and thiol groups content.
RESULTS: SIRT3 expression in the biopsies of the failing human hearts showed a 46% decrease in the expression levels of obese patients in comparison to the non-obese patients (p=0.0219). Remarkably, body mass index was associated with protein acetylation (0.627; p = 0.035), suggesting that the acetylation profiles of the failing hearts of obese patients are partly mediated by a reduction in SIRT3, which is also associated with higher BNP levels, indicating a more severe ventricular dysfunction (-0.636; p = 0.043). Accordingly, obese rats demonstrated a SIRT3 mitochondrial expression decrease of 22% concomitantly with a hyperacetylated mitochondrial profile, including CypD. Cardiac mitochondria from obese animals were 2.5-fold more prone to mPTP opening than the controls.
CONCLUSION: Our results indicate that obesity reduces SIRT3 expression and that CypD hyperacetylation increases mPTP opening, suggesting that the activation of SIRT3 might be a potential target to decrease ventricular dysfunction and slow the progression of heart failure. © Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Entities:  

Keywords:  Acetylation; Biopsies; Heart failure; Mitochondria; Obesity; Sirtuins

Mesh:

Substances:

Year:  2019        PMID: 31464387     DOI: 10.33594/000000151

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  15 in total

1.  Adrenergic Receptor Regulation of Mitochondrial Function in Cardiomyocytes.

Authors:  Peyton B Sandroni; Kelsey H Fisher-Wellman; Brian C Jensen
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

Review 2.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

Review 3.  Mitochondrial Ca2+, redox environment and ROS emission in heart failure: Two sides of the same coin?

Authors:  Sonia Cortassa; Magdalena Juhaszova; Miguel A Aon; Dmitry B Zorov; Steven J Sollott
Journal:  J Mol Cell Cardiol       Date:  2020-12-07       Impact factor: 5.000

4.  Oxoeicosanoid receptor inhibition alleviates acute myocardial infarction through activation of BCAT1.

Authors:  Qiong Lai; Guangying Yuan; Le Shen; Lu Zhang; Fei Fu; Zeliang Liu; Yuanyuan Zhang; Junping Kou; Shijia Liu; Boyang Yu; Fang Li
Journal:  Basic Res Cardiol       Date:  2021-01-23       Impact factor: 17.165

Review 5.  Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.

Authors:  Ling He; Fuxiang Liu; Juxiang Li
Journal:  Cardiovasc Toxicol       Date:  2021-01-12       Impact factor: 3.231

6.  The Protective Effects of Mogroside V Against Neuronal Damages by Attenuating Mitochondrial Dysfunction via Upregulating Sirtuin3.

Authors:  Hanjiang Luo; Caixia Peng; Xiaofeng Xu; Yuntao Peng; Fang Shi; Qinghua Li; Jianghui Dong; Min Chen
Journal:  Mol Neurobiol       Date:  2022-01-18       Impact factor: 5.590

7.  Role of oxidative metabolism in osseointegration during spinal fusion.

Authors:  Laura C Shum; Alex M Hollenberg; Avionna L Baldwin; Brianna H Kalicharan; Noorullah Maqsoodi; Paul T Rubery; Addisu Mesfin; Roman A Eliseev
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

8.  Resveratrol Prevents Right Ventricle Remodeling and Dysfunction in Monocrotaline-Induced Pulmonary Arterial Hypertension with a Limited Improvement in the Lung Vasculature.

Authors:  Eduardo Vázquez-Garza; Judith Bernal-Ramírez; Carlos Jerjes-Sánchez; Omar Lozano; Edgar Acuña-Morín; Mariana Vanoye-Tamez; Martín R Ramos-González; Héctor Chapoy-Villanueva; Luis Pérez-Plata; Luis Sánchez-Trujillo; Guillermo Torre-Amione; Alicia Ramírez-Rivera; Gerardo García-Rivas
Journal:  Oxid Med Cell Longev       Date:  2020-02-03       Impact factor: 6.543

Review 9.  What Is the Role of the Inflammation in the Pathogenesis of Heart Failure?

Authors:  Elena C Castillo; Eduardo Vázquez-Garza; David Yee-Trejo; Gerardo García-Rivas; Guillermo Torre-Amione
Journal:  Curr Cardiol Rep       Date:  2020-09-10       Impact factor: 2.931

10.  Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension.

Authors:  Judith Bernal-Ramírez; Christian Silva-Platas; Carlos Jerjes-Sánchez; Martín R Ramos-González; Eduardo Vázquez-Garza; Héctor Chapoy-Villanueva; Alicia Ramírez-Rivera; Ángel Zarain-Herzberg; Noemi García; Gerardo García-Rivas
Journal:  Oxid Med Cell Longev       Date:  2021-06-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.